How many clinical-trial readouts are scheduled for June 2027?

pdufa.bio currently tracks 48 clinical-trial readouts with dates in June 2027, each linked to a primary source. The list updates as new filings appear and dates shift.

What is a clinical-trial readout date?

A readout date is the estimated time a trial reports topline results, based on its registered primary-completion date; these are estimates and shift.

Does pdufa.bio predict whether these will be approved?

No. We do not publish per-drug approval probabilities. We provide the verified facts, primary-source links, and historical base rates so you can judge for yourself.

pdufa.bio

Calendar Readouts Devices Decisions Approvals/yr Trial odds Learn Research Methodology

Home › Readouts › June 2027

June 2027 clinical-trial readouts

trial-readout estimates for June 2027, each row linked to its primary source. Readout dates are estimated primary-completion windows from ClinicalTrials.gov and shift.

← May 2027 July 2027 →

48 readouts

BLLN · Jun 2027 (est.)

5-Fluorouracil — Gastroesophageal Adenocarcinoma

BMEA · Jun 2027 (est.)

icovamenib — Type 2 Diabetes

CRSP · Jun 2027 (est.)

CTX001 — Cardiovascular

BSX · Jun 2027 (est.)

Colchicine — Hepatocellular Carcinoma

CRVS · Jun 2027 (est.)

Soquelitinib — Atopic Dermatitis

EIKN · Jun 2027 (est.)

EIK1001 — Advanced Solid Tumor

VRCA · Jun 2027 (est.)

Part 1: VP-315 3 Day Dosing/Week — Common Warts

VSTM · Jun 2027 (est.)

avutometinib — Pancreatic Ductal Adenocarcinoma (PDAC)

APRE · Jun 2027 (est.)

APR-246 + azacitidine — Advanced Solid Tumor

ARWR · Jun 2027 (est.)

Plozasiran — Alzheimer Disease

ASND · Jun 2027 (est.)

TransCon CNP — Hypoparathyroidism

AVLN · Jun 2027 (est.)

AP01 — Pulmonary Fibrosis

TNGX · Jun 2027 (est.)

TNG462 — PDAC

TARA · Jun 2027 (est.)

Choline Chloride for Injection — Choline Deficiency

KYMR · Jun 2027 (est.)

KT-621 — Atopic Dermatitis

FDMT · Jun 2027 (est.)

4D-150 IVT — Macular Neovascularization Secondary to Age-Related Macular Degeneration

FTH · Jun 2027 (est.)

SNS-101 — Solid Tumor, Adult

IMMP · Jun 2027 (est.)

eftilagimod alfa — Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)

INBX · Jun 2027 (est.)

INBRX-106 — Triple Negative Breast Cancer

INKT · Jun 2027 (est.)

agenT-797 — Pneumonia

IONS · Jun 2027 (est.)

Olezarsen — Familial Chylomicronemia Syndrome

IPHA · Jun 2027 (est.)

Monalizumab — Non Small Cell Lung Cancer

IRON · Jun 2027 (est.)

DISC-1459 — Sickle Cell Disease

JAZZ · Jun 2027 (est.)

CPX-351 — Acute Myeloid Leukemia

KPTI · Jun 2027 (est.)

Selinexor — Myelofibrosis

KYTX · Jun 2027 (est.)

Standard of Care Treatment — Rheumatoid Arthritis

SVRA · Jun 2027 (est.)

Molgramostim — Autoimmune Pulmonary Alveolar Proteinosis

LBRX · Jun 2027 (est.)

LB-102 — Schizophrenia

LNTH · Jun 2027 (est.)

PI-2620 — Alzheimer Disease

MANE · Jun 2027 (est.)

VDPHL01 — Androgenetic Alopecia (AGA)

NMRA · Jun 2027 (est.)

NMRA-335140 — Major Depressive Disorder

ORKA · Jun 2027 (est.)

ORKA-001 — Plaque Psoriasis

PHVS · Jun 2027 (est.)

deucrictibant — Hereditary Angioedema

RIGL · Jun 2027 (est.)

Fostamatinib Disodium — Targeted Therapy

RXRX · Jun 2027 (est.)

REC-2282 — Familial Adenomatous Polyposis

SLDB · Jun 2027 (est.)

SGT-003 — Catecholaminergic Polymorphic Ventricular Tachycardia

MIST · Jun 2027 (est.)

Etripamil NS — Paroxysmal Supraventricular Tachycardia

NVS · Jun 2027 (est.)

Remibrutinib — Hidradenitis Suppurativa

SMMT · Jun 2027 (est.)

Ivonescimab — Thymus Carcinoma

BLTE · Jun 2027 (est.)

Tinlarebant — Geographic Atrophy

IMNN · Jun 2027 (est.)

IMNN-001 — Ovarian Cancer

INDP · Jun 2027 (est.)

Decoy20 — Solid Tumor, Adult

LEGN · Jun 2027 (est.)

LCAR-B38M CAR-T Cell — Relapsed/Refractory B-cell Malignancies

MIRM · Jun 2027 (est.)

BJT-778 — Chronic Hepatitis D Infection

PBYI · Jun 2027 (est.)

neratinib — Hormone Receptor Positive HER-2 Negative Breast Cancer

RIGL · Jun 2027 (est.)

Fostamatinib Disodium — Mutant IDH1 Inhibitor Olutasidenib

ACRS · Jun 2027 (est.)

A-101 — Metastatic Pancreatic Ductal Adenocarcinoma

ALNY · Jun 2027 (est.)

ALN-6400 — Von Willebrand Disease (VWD)

Looking for an approval probability for these? We deliberately don't publish one — here's why, and what we show instead (verified history + base rates).